Shareholding disclosure

Cosmo Pharmaceuticals NV, Amsterdam

Declared position

9.5%

Threshold

Crossed downwards

Timeline

Published

18.12.2019

Transaction

15.08.2019

Transfer date

15.08.2019

Voting rights breakdown

Voting rights acquired3.005%

Voting rights sold9.5%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAJC300079

Beneficial owner

Cosmo Pharmaceuticals NV, Amsterdam

Declared address

Cosmo Pharmaceuticals NV, Amsterdam

Purchase of own shares

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Cosmo Pharmaceuticals NV, Amsterdam

Cosmo N.V.18.12.2019TAJC300079

Disclosure summary

Cosmo Pharmaceuticals NV, Amsterdam disclosed a holding in Cosmo N.V. on the disposal side, published by SIX Exchange Regulation on 18.12.2019, at 9.5% of voting rights. Notice category: Single shareholder.

Disclosed position

9.5%

Voting rights sold

Voting rights acquired3.005%

Voting rights sold9.5%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Cosmo Pharmaceuticals NV, Amsterdam disclosed a holding in Cosmo N.V., published on 18.12.2019.

Publication date18.12.2019

Transaction date15.08.2019

Transfer date15.08.2019

Issuing companyCosmo N.V.

Beneficial ownerCosmo Pharmaceuticals NV, Amsterdam

Declared addressCosmo Pharmaceuticals NV, Amsterdam

CategorySingle shareholder

Voting rights acquired3.005%

Voting rights sold9.5%

Below threshold0%

ExchangeXSWX

Notification IDTAJC300079

Conditions

Purchase of own shares

Source: SIX Exchange Regulation · Publication date: 18.12.2019

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open